Table 1.
Control (N=97) |
Schizophrenia (N=90) |
t or χ2 | df | p | |||
---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | ||||
Age | 36.74 | 11.56 | 36.94 | 11.44 | -0.12 | 184.23 | 0.90 |
Gender (N) | |||||||
Male | 72 | 65 | 0.18 | 1 | 0.66 | ||
Female | 25 | 25 | |||||
Duration of illness in COBRE (years) | 11.33 | 13.53 | |||||
PANSS in COBRE | |||||||
Total score | 59.54 | 19.89 | |||||
Positive score | 15.24 | 5.25 | |||||
Negative score | 14.8 | 5.45 | |||||
General score | 29.5 | 9.19 | |||||
SAPS in NMorphCH | 42 | 34.39 | |||||
SANS in NMorphCH | 53.31 | 26.27 | |||||
LNS | -0.02 | 1.01 | -0.99 | 1.26 | 5.82 | 170.65 | <0.001 |
SD: standard deviation, df: degrees of freedom, COBRE: center for biomedical research excellence, LNS: letter number sequencing, PANSS: positive and negative syndrome scale, SAPS: the scale for the assessment of positive symptoms, SANS: the scale for the assessment of negative symptoms